Quick Answer
Whitehawk Therapeutics, Inc. reported Stockholders Equity of $136.31 million for fiscal year 2025.
Whitehawk Therapeutics, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $136.31M | +159.7% |
| 2024 | $52.48M | -50.1% |
| 2023 | $105.19M | -33.6% |
| 2022 | $158.38M | +16.1% |
| 2021 | $136.41M | +1197.2% |
| 2020 | -$12.43M | -36.7% |
| 2019 | -$9.09M | -115.5% |
| 2018 | $58.67M | +236.5% |
| 2017 | $17.44M | +120.2% |
| 2016 | -$86.22M | -29.5% |
| 2015 | -$66.55M | -42827.2% |
| 2014 | -$155.0K | -24.8% |
| 2013 | -$124.2K | -30.0% |
| 2012 | -$95.5K | -40.1% |
| 2011 | -$68.2K | -66.3% |
| 2010 | -$41.0K | -120.4% |
| 2009 | -$18.6K | -1428.3% |
| 2008 | $1.4K | -96.0% |
| 2007 | $35.0K | — |
| 2007 | $0.00 | — |
| 2007 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $157.17M | +128.2% | -8.7% |
| June 30, 2025 | $172.07M | +118.4% | -22.4% |
| March 31, 2025 | $221.73M | +145.1% | +322.5% |
| December 31, 2024 | $52.48M | -50.1% | -23.8% |
| September 30, 2024 | $68.87M | -41.7% | -12.6% |
| June 30, 2024 | $78.79M | -40.0% | -12.9% |
| March 31, 2024 | $90.46M | -38.0% | -14.0% |
| December 31, 2023 | $105.19M | -33.6% | -11.0% |
- Whitehawk Therapeutics, Inc. showed an increase of +159.7% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Whitehawk Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: